» Articles » PMID: 6387263

Long-term Effect of Captopril on Kidney Function in Various Forms of Hypertension

Overview
Journal Klin Wochenschr
Specialty General Medicine
Date 1984 Aug 1
PMID 6387263
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

To study long-term effects of captopril on renal function in patients with various forms of severe hypertension, serum creatinine values were monitored in 76 patients under captopril therapy over a period of up to 3 years. Three different groups were formed: patients with essential hypertension (n = 37); patients with renovascular hypertension (n = 20); patients with renal parenchymatous hypertension (n = 19). In each of the three groups reduction in blood pressure was accompanied by increases in serum creatinine. However, both changes were more pronounced in patients with renovascular hypertension. In this group only the rise in creatinine was statistically significant and showed a slight progression with duration of captopril treatment. Group specific analysis revealed that the increase was smaller in patients with unilateral (n = 16) renovascular disease than in those with bilateral (n = 4) involvement, but in the former it was still significantly higher than in patients with essential or renal parenchymatous hypertension. Separation of patients according to the underlying disease of renovascular hypertension showed that renal function deteriorated less in patients with arteriosclerotic origin (n = 10) than in those with fibromuscular dysplasia (n = 8). Statistical evaluation of subjects with renovascular and essential hypertension still revealed significant differences in creatinine when the patients with initial plasma renin activity (PRA) below and above 6 ng/ml X 3 h were compared separately. A significant correlation (r = 0.73; P less than 0.05) between blood pressure reduction and creatinine changes was obtained only for patients with renovascular hypertension.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Renal protection and antihypertensive drugs: current status.

Salvetti A, Mattei P, Sudano I Drugs. 1999; 57(5):665-93.

PMID: 10353294 DOI: 10.2165/00003495-199957050-00002.


[Angiotensin-converting enzyme inhibition: direct and indirect mechanisms].

Stumpe K Klin Wochenschr. 1985; 63(18):897-906.

PMID: 2997540 DOI: 10.1007/BF01738143.


Renal effects of angiotensin converting enzyme inhibitors: nondiabetic chronic renal disease.

Opsahl J, Abraham P, Keane W Cardiovasc Drugs Ther. 1990; 4(1):221-8.

PMID: 2285614 DOI: 10.1007/BF01857636.


Angiotensin converting enzyme inhibitors: comparative structure, pharmacokinetics, and pharmacodynamics.

Thind G Cardiovasc Drugs Ther. 1990; 4(1):199-206.

PMID: 2285612 DOI: 10.1007/BF01857634.


Angiotensin-converting enzyme inhibitors in chronic renal failure.

Opsahl J, Abraham P, Keane W Drugs. 1990; 39 Suppl 2:23-32.

PMID: 2188823 DOI: 10.2165/00003495-199000392-00006.

References
1.
Haber E, Koerner T, PAGE L, KLIMAN B, Purnode A . Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab. 1969; 29(10):1349-55. DOI: 10.1210/jcem-29-10-1349. View

2.
Collste P, Haglund K, Lundgren G, Magnusson G, Ostman J . Reversible renal failure during treatment with captopril. Br Med J. 1979; 2(6190):612-3. PMC: 1596482. DOI: 10.1136/bmj.2.6190.612-c. View

3.
Curtis J, Luke R, Whelchel J, Diethelm A, Jones P, DUSTAN H . Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension. N Engl J Med. 1983; 308(7):377-81. DOI: 10.1056/NEJM198302173080707. View

4.
Farrow P, Wilkinson R . Reversible renal failure during treatment with captopril. Br Med J. 1979; 1(6179):1680. PMC: 1599243. DOI: 10.1136/bmj.1.6179.1680. View

5.
Seedat Y . Nephrotic syndrome from captopril. S Afr Med J. 1980; 57(11):390. View